Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Atecor 50mg Tablet – PA0711/003/002
- Ativan 4mg/ml Solution for Injection – PA0822/090/002
- Centyl K 2.5mg + 573mg Modified Release Tablet – PA22650/002/002
- Creon 25000 Gastro-resistant Capsule – PA2010/008/002
- Erwinase 10,000 Units Powder for Solution for Injection – PA1020/002/001
- Galfer 305mg Tablet – PA0126/314/001
- Isoptin 240mg Prolonged Release Tablet – PA2010/003/005
- Maxibar 98.45% w/w Powder for Oral Solution – PA1826/002/001
- Perdamel 1mg Film Coated Tablet – PA0126/169/003
- Propafenone hydrochloride 150mg Tablet – PA2315/116/001
- Propafenone hydrochloride 300mg Tablet – PA2315/116/002
- Telfast 120mg Film Coated Tablet – PA0540/078/002
- Visudyne 15mg Powder for Solution for Infusion – EU/1/00/140/001
The following shortage has been resolved and supply has resumed to the Irish market:
- Bendamustine 100mg Powder for Solution for Infusion – PA1380/163/002
- Erythroped SF 250mg/5ml Granules for Oral Solution – PA1142/006/001
- Lanoxin PG 50mcg/ml Elixir – PA1691/001/002
- Lanoxin PG 62.5mcg Tablet – PA1691/001/003
- Lanoxin PG 250mcg Tablet – PA1691/001/004
- Minims Atropine Sulphate 1% Eye Drop Solution – PA0555/017/001
- Minims Prednisolone Sodium Phosphate 0.5% Eye Drop Solution – PA22698/016/001
- Prozamel 20mg Capsule – PA0126/110/001
- Venlafaxine XL 37.5mg Capsule – PA1347/036/001
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.